Power Law company profile

Kodiak Sciences

Biotech & Life Sciences · Palo Alto, United States · Founded 2009 · IPO 2018 Unicorn

Designing and developing novel therapies for the treatment of retinal disease

Valuation

$2.55B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

2 investors on Kodiak Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

ArrowMark Partners

Perceptive Advisors

Global footprint

Where Kodiak Sciences has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States89.1%

🇨🇭 Switzerland8.5%

🇨🇦 Canada2.3%

3 countries shown

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States86.2%

🇮🇳 India11.5%

Top 2 markets shown

Patent intelligence

$34M patent portfolio · 22 active families

Estimated portfolio value

$34M

1.4% of market cap · 9.5× smaller than top peer Genmab ($328M)

22 active patent families

Where Kodiak Sciences innovates Antiendomysial antibodiesMolecular biologyDiseaseBiochemistryAnti antibody

Where Kodiak Sciences concentrates vs peers

Each axis is a top-10 topic across Kodiak Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Kodiak Sciences

An AI-synthesized read of the highest-engagement posts about Kodiak Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kodiak Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles